BUFFALO, N.Y. — Toronto-based RIV Capital and its New York medical cannabis brand, Etain, will begin to move forward with adult use dispensaries following a key approval from the state’s Cannabis Control Board.
The state granted licenses last week for six medical cannabis companies to start the transition to the adult-use market, and Etain was one of them.
With its 68,000-square-foot cannabis facility at Buffalo Lakeside Commerce Park, RIV Capital will be the largest tenant of Zephyr Investments LLC’s planned 1.375M-square-foot cannabis production and R&D facility.
